ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer

被引：0
|
作者：
Antje M. Richter
Steffen Kiehl
Nicole Köger
Janina Breuer
Thorsten Stiewe
Reinhard H. Dammann
机构：
[1] Justus-Liebig-University Giessen,Institute for Genetics
[2] Philipps-University Marburg,Institute of Molecular Oncology
[3] Universities of Giessen and Marburg Lung Center,German Center for Lung Research (DZL)
来源：
Clinical Epigenetics | 2017年 / 9卷
关键词：
Lung cancer; ZAR1 (zygote arrest 1); Tumour suppressor; DNA methylation; Epigenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
    Richter, Antje M.
    Kiehl, Steffen
    Koger, Nicole
    Breuer, Janina
    Stiewe, Thorsten
    Dammann, Reinhard H.
    CLINICAL EPIGENETICS, 2017, 9
  • [2] Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
    Verena Deutschmeyer
    Janina Breuer
    Sara K. Walesch
    Anna M. Sokol
    Johannes Graumann
    Marek Bartkuhn
    Thomas Boettger
    Oliver Rossbach
    Antje M. Richter
    Clinical Epigenetics, 2019, 11
  • [3] Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
    Deutschmeyer, Verena
    Breuer, Janina
    Walesch, Sara K.
    Sokol, Anna M.
    Graumann, Johannes
    Bartkuhn, Marek
    Boettger, Thomas
    Rossbach, Oliver
    Richter, Antje M.
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [4] Identification of epigenetically inactivated tumour suppressor genes in oligodendroglial tumours
    Hofmann, L.
    Felsberg, J.
    Wolter, M.
    Ehrentraut, D.
    Reifenberger, G.
    Waha, A.
    ACTA NEUROPATHOLOGICA, 2006, 112 (03) : 373 - 373
  • [5] The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors
    Deutschmeyer, Verena E.
    Richter, Antje M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (02):
  • [6] Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer
    K O’Leary
    A Shia
    F Cavicchioli
    V Haley
    A Comino
    M Merlano
    F Mauri
    K Walter
    M Lackner
    M B Wischnewsky
    T Crook
    C Lo Nigro
    P Schmid
    British Journal of Cancer, 2015, 113 : 970 - 978
  • [7] Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer
    O'Leary, K.
    Shia, A.
    Cavicchioli, F.
    Haley, V.
    Comino, A.
    Merlano, M.
    Mauri, F.
    Walter, K.
    Lackner, M.
    Wischnewsky, M. B.
    Crook, T.
    Lo Nigro, C.
    Schmid, P.
    BRITISH JOURNAL OF CANCER, 2015, 113 (06) : 970 - 978
  • [8] The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
    Luke B Hesson
    Thomas L Dunwell
    Wendy N Cooper
    Daniel Catchpoole
    Anna T Brini
    Raffaella Chiaramonte
    Mike Griffiths
    Andrew D Chalmers
    Eamonn R Maher
    Farida Latif
    Molecular Cancer, 8
  • [9] The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
    Hesson, Luke B.
    Dunwell, Thomas L.
    Cooper, Wendy N.
    Catchpoole, Daniel
    Brini, Anna T.
    Chiaramonte, Raffaella
    Griffiths, Mike
    Chalmers, Andrew D.
    Maher, Eamonn R.
    Latif, Farida
    MOLECULAR CANCER, 2009, 8
  • [10] IDENTIFICATION OF ENDOGLIN (CD105) AS AN EPIGENETICALLY REGULATED CANDIDATE TUMOUR SUPPRESSOR GENE IN LUNG CANCER
    O'Leary, K.
    Shia, A.
    Haley, V.
    Cavicchioli, F.
    Comino, A.
    Vanella, P.
    Wischnewsky, M.
    Crook, T.
    Lo Nigro, C.
    Schmid, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 73 - 74
12345